Andrew L. Himelstein
- Co-authors
- Stephen S. GrubbsCharles L. ShapiroPaul J. NovotnyS PoddaJared C. FosterChristine RichardsonLéonard V. SmithMaureen Ward
- Topics
- Radiopharmaceutical Chemistry and Applications (6 papers)RNA Interference and Gene Delivery (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
- Partner nations
- United StatesItaly
In The Last Decade
Andrew L. Himelstein
16 papers receiving 587 citations
Peers
Comparison fields: 5 of 64
- Oncology 339
- Molecular Biology 226
- Genetics 127
- Surgery 109
- Radiology, Nuclear Medicine and Imaging 96
Countries citing papers authored by Andrew L. Himelstein
This map shows the geographic impact of Andrew L. Himelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Himelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Himelstein more than expected).
Fields of papers citing papers by Andrew L. Himelstein
This network shows the impact of papers produced by Andrew L. Himelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Himelstein. The network helps show where Andrew L. Himelstein may publish in the future.
Co-authorship network of co-authors of Andrew L. Himelstein
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew L. Himelstein. A scholar is included among the top collaborators of Andrew L. Himelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew L. Himelstein. Andrew L. Himelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 216 | |
| 3 | 14 | |
| 4 | Anti-CD22 radioimmunotherapy (RIT) combined with anti-CD20 immunotherapy in aggressive non-Hodgkin lymphoma (NHL): Phase I results | 1 |
| 5 | 1 | |
| 6 | Novel combination of anti-CD22 radioimmunotherapy and anti-CD20 immunotherapy targeting two different antigens in non-Hodgkin lymphoma (NHL): Initial clinical experience | 2 |
| 7 | 39 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 45 | |
| 11 | 9 | |
| 12 | 0 | |
| 13 | 19 | |
| 14 | 172 | |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 7 |
About Andrew L. Himelstein
Andrew L. Himelstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Internal Medicine and Oncology, having authored 17 papers that have together received 595 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), RNA Interference and Gene Delivery (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (339 citations), Hematology (83 citations) and Orthopedics and Sports Medicine (45 citations). Andrew L. Himelstein has collaborated with scholars based in United States and Italy. Frequent co-authors include Stephen S. Grubbs, Charles L. Shapiro, Paul J. Novotny, S Podda, Jared C. Foster, Christine Richardson, Léonard V. Smith, Maureen Ward, A Bank and Ira Pastan. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.